When you absolutely have to recruit patients on time
Home News
Successful site closure — a multinational Phase III study in ulcerative colitis
A Phase III clinical study of active ulcerative colitis treatment has moved into its final stage at Accell Clinical Research. The study commenced in August 2012 and included 30 sites
Two large studies starting in Russia – treatment for cardiovascular disease
Accell has commenced two Phase III clinical trials testing the efficacy of a new drug for prevention of major cardiovascular events in risk group patients. Thirty Russian sites managed by
Two new clinical trials in oncology, Russia
One of Accell’s clients, a developer of targeted therapeutics for various tumor types, starts 2 new Phase II clinical trials in Russia. Accell has been performing other clinical studies for
Accell Clinical Research participated in an international medical conference
Natalia Nayanova, Director, Clinical Operations at Accell Clinical Research, spoke at annual international scientific conference “Multidisciplinary clinic in ХХI. Extreme medicine” (St. Petersburg, April, 9-11). The topic of presentation was “High-quality